• Profile
Close

Seroprevalence of SARS-CoV-2 following the largest initial epidemic wave in the United States: Findings from New York City, May 13-July 21, 2020

The Journal of Infectious Diseases Apr 15, 2021

Pathela P, Crawley A, Weiss D, et al. - The US epicenter of the Spring 2020 COVID-19 pandemic was New York City (NYC). Based on a large serosurvey of adult NYC residents (May 13-July 21, 2020), researchers sought to report on the seroprevalence of SARS-CoV-2 infection and correlates of seropositivity immediately after the first wave. Findings revealed infection of just under one-quarter of NYC adults in the first few months of the COVID-19 epidemic. Seroprevalence was noted to be high (>30%) among Black and Hispanic individuals, people from high poverty neighborhoods, and people in health care or essential worker industry sectors. Seropositivity was observed in correlation with COVID-19 symptom history. Following were the other risk factors: gender, age, race/ethnicity, residential area, employment sector, working outside the home, contact with a COVID-19 case, obesity, and increasing numbers of household members. Researchers suggest necessity for effective interventions for at-risk groups during ongoing transmission in view of the observed disparities in infection risk.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay